{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:32:02Z","timestamp":1788831122178,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2016YFC1306300"],"award-info":[{"award-number":["2016YFC1306300"]}]},{"name":"National Key Research and Development Program of China","award":["2018YFC1312001"],"award-info":[{"award-number":["2018YFC1312001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61633018"],"award-info":[{"award-number":["61633018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82020108013"],"award-info":[{"award-number":["82020108013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Health Commission","award":["2020YJZX0111"],"award-info":[{"award-number":["2020YJZX0111"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Subjective cognitive decline (SCD) represents a cognitively normal state but at an increased risk for developing Alzheimer\u2019s disease (AD). Recognizing the glucose metabolic biomarkers of SCD could facilitate the location of areas with metabolic changes at an ultra-early stage. The objective of this study was to explore glucose metabolic biomarkers of SCD at the region of interest (ROI) level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study was based on cohorts from two tertiary medical centers, and it was part of the SILCODE project (NCT03370744). Twenty-six normal control (NC) cases and 32 SCD cases were in cohort 1; 36 NCs, 23 cases of SCD, 32 cases of amnestic mild cognitive impairment (aMCIs), 32 cases of AD dementia (ADDs), and 22 cases of dementia with Lewy bodies (DLBs) were in cohort 2. Each subject underwent [18F]fluoro-2-deoxyglucose positron emission tomography (PET) imaging and magnetic resonance imaging (MRI), and subjects from cohort 1 additionally underwent amyloid-PET scanning. The ROI analysis was based on the Anatomical Automatic Labeling (AAL) template; multiple permutation tests and repeated cross-validations were conducted to determine the metabolic differences between NC and SCD cases. In addition, receiver operating characteristic curves were used to evaluate the capabilities of potential glucose metabolic biomarkers in distinguishing different groups. Pearson correlation analysis was also performed to explore the correlation between glucose metabolic biomarkers and neuropsychological scales or amyloid deposition.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Only the right middle temporal gyrus (RMTG) passed the methodological verification, and its metabolic levels were correlated with the degrees of complaints (<jats:italic>R<\/jats:italic>\u2009=\u2009\u2212\u20090.239, <jats:italic>p<\/jats:italic>\u2009=\u20090.009), depression (<jats:italic>R<\/jats:italic>\u2009=\u2009\u2212\u20090.200, <jats:italic>p<\/jats:italic>\u2009=\u20090.030), and abilities of delayed memory (<jats:italic>R<\/jats:italic>\u2009=\u20090.207, <jats:italic>p<\/jats:italic>\u2009=\u20090.025), and were weakly correlated with cortical amyloid deposition (<jats:italic>R<\/jats:italic>\u2009=\u2009\u2212\u20090.246, <jats:italic>p<\/jats:italic>\u2009=\u20090.066). Furthermore, RMTG metabolism gradually decreased across the cognitive continuum, and its diagnostic efficiency was comparable (NC vs. ADD, aMCI, or DLB) or even superior (NC vs. SCD) to that of the metabolism of the posterior cingulate cortex or precuneus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings suggest that the hypometabolism of RMTG could be a typical feature of SCD, and the large-scale hypometabolism in patients with symptomatic stages of AD may start from the RMTG, which gradually progresses starting in the preclinical stage. The specificity of identifying SCD from the perspective of self-perceived symptoms is likely to be increased by the detection of RMTG metabolism.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-021-00811-w","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T16:05:30Z","timestamp":1617811530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population"],"prefix":"10.1186","volume":"13","author":[{"given":"Qiu-Yue","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao-Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4948-3683","authenticated-orcid":false,"given":"Jie-Hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"issue":"2","key":"811_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2):312\u201339. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001.","journal-title":"Cell."},{"issue":"6420","key":"811_CR2","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1126\/science.aau0437","volume":"362","author":"TE Golde","year":"2018","unstructured":"Golde TE, DeKosky ST, Galasko D. Alzheimer\u2019s disease: the right drug, the right time. Science. 2018;362(6420):1250\u20131. https:\/\/doi.org\/10.1126\/science.aau0437.","journal-title":"Science."},{"issue":"3","key":"811_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1474-4422(19)30368-0","volume":"19","author":"F Jessen","year":"2020","unstructured":"Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19(3):271\u20138. https:\/\/doi.org\/10.1016\/S1474-4422(19)30368-0.","journal-title":"Lancet Neurol"},{"issue":"2","key":"811_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.dadm.2015.02.005","volume":"1","author":"A Koppara","year":"2015","unstructured":"Koppara A, Wagner M, Lange C, Ernst A, Wiese B, Konig HH, et al. Cognitive performance before and after the onset of subjective cognitive decline in old age. Alzheimers Dement (Amst). 2015;1(2):194\u2013205. https:\/\/doi.org\/10.1016\/j.dadm.2015.02.005.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"11","key":"811_CR5","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jalz.2014.11.006","volume":"11","author":"M Ronnlund","year":"2015","unstructured":"Ronnlund M, Sundstrom A, Adolfsson R, Nilsson LG. Subjective memory impairment in older adults predicts future dementia independent of baseline memory performance: evidence from the Betula prospective cohort study. Alzheimers Dement. 2015;11(11):1385\u201392. https:\/\/doi.org\/10.1016\/j.jalz.2014.11.006.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"811_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jalz.2015.12.013","volume":"12","author":"RF Buckley","year":"2016","unstructured":"Buckley RF, Maruff P, Ames D, Bourgeat P, Martins RN, Masters CL, et al. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2016;12(7):796\u2013804. https:\/\/doi.org\/10.1016\/j.jalz.2015.12.013.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"811_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14(4):535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"811_CR8","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00259-018-3985-4","volume":"45","author":"I Apostolova","year":"2018","unstructured":"Apostolova I, Lange C, Suppa P, Spies L, Klutmann S, Adam G, et al. Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment. Eur J Nucl Med Mol Imaging. 2018;45(8):1417\u201322. https:\/\/doi.org\/10.1007\/s00259-018-3985-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"811_CR9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","volume":"32","author":"SM Landau","year":"2011","unstructured":"Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, et al. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging. 2011;32(7):1207\u201318. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.07.002.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"811_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study. Lancet Neurol. 2018;17(3):241\u201350. https:\/\/doi.org\/10.1016\/S1474-4422(18)30028-0.","journal-title":"Lancet Neurol"},{"issue":"1","key":"811_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-020-00395-3","volume":"15","author":"X Wang","year":"2020","unstructured":"Wang X, Huang W, Su L, Xing Y, Jessen F, Sun Y, et al. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer\u2019s disease. Mol Neurodegener. 2020;15(1):55. https:\/\/doi.org\/10.1186\/s13024-020-00395-3.","journal-title":"Mol Neurodegener"},{"issue":"13","key":"811_CR12","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1212\/WNL.0b013e31826c1a8d","volume":"79","author":"L Scheef","year":"2012","unstructured":"Scheef L, Spottke A, Daerr M, Joe A, Striepens N, Kolsch H, et al. Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment. Neurology. 2012;79(13):1332\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e31826c1a8d.","journal-title":"Neurology."},{"issue":"6","key":"811_CR13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.biopsych.2007.05.030","volume":"63","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, De Santi S, Brys M, Tsui WH, Pirraglia E, Glodzik-Sobanska L, et al. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biol Psychiatry. 2008;63(6):609\u201318. https:\/\/doi.org\/10.1016\/j.biopsych.2007.05.030.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"811_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/mpr.1499","volume":"25","author":"Q Wu","year":"2016","unstructured":"Wu Q. Subjective cognitive impairment of older adults: a comparison between the US and China. Int J Methods Psychiatr Res. 2016;25(1):68\u201375. https:\/\/doi.org\/10.1002\/mpr.1499.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"6","key":"811_CR15","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/ageing\/afx077","volume":"46","author":"JD Jackson","year":"2017","unstructured":"Jackson JD, Rentz DM, Aghjayan SL, Buckley RF, Meneide TF, Sperling RA, et al. Subjective cognitive concerns are associated with objective memory performance in Caucasian but not African-American persons. Age Ageing. 2017;46(6):988\u201393. https:\/\/doi.org\/10.1093\/ageing\/afx077.","journal-title":"Age Ageing"},{"issue":"7","key":"811_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028188","volume":"9","author":"X Li","year":"2019","unstructured":"Li X, Wang X, Su L, Hu X, Han Y. Sino Longitudinal Study on Cognitive Decline (SILCODE): protocol for a Chinese longitudinal observational study to develop risk prediction models of conversion to mild cognitive impairment in individuals with subjective cognitive decline. BMJ Open. 2019;9(7):e028188. https:\/\/doi.org\/10.1136\/bmjopen-2018-028188.","journal-title":"BMJ Open"},{"key":"811_CR17","doi-asserted-by":"publisher","first-page":"605734","DOI":"10.3389\/fcell.2020.605734","volume":"8","author":"TR Li","year":"2020","unstructured":"Li TR, Wu Y, Jiang JJ, Lin H, Han CL, Jiang JH, et al. Radiomics analysis of magnetic resonance imaging facilitates the identification of preclinical Alzheimer\u2019s disease: an exploratory study. Front Cell Dev Biol. 2020;8:605734. https:\/\/doi.org\/10.3389\/fcell.2020.605734.","journal-title":"Front Cell Dev Biol"},{"issue":"1101","key":"811_CR18","doi-asserted-by":"publisher","first-page":"20181020","DOI":"10.1259\/bjr.20181020","volume":"92","author":"D Fakhry-Darian","year":"2019","unstructured":"Fakhry-Darian D, Patel NH, Khan S, Barwick T, Svensson W, Khan S, et al. Optimisation and usefulness of quantitative analysis of (18) F-florbetapir PET. Br J Radiol. 2019;92(1101):20181020. https:\/\/doi.org\/10.1259\/bjr.20181020.","journal-title":"Br J Radiol"},{"issue":"6","key":"811_CR19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2014;10(6):844\u201352. https:\/\/doi.org\/10.1016\/j.jalz.2014.01.001.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"811_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3233\/JAD-190501","volume":"72","author":"G Chen","year":"2019","unstructured":"Chen G, Yang K, Du W, Hu X, Han Y. Clinical characteristics in subjective cognitive decline with and without worry: baseline investigation of the SILCODE study. J Alzheimers Dis. 2019;72(2):443\u201354. https:\/\/doi.org\/10.3233\/JAD-190501.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"811_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3233\/JAD-140276","volume":"42","author":"MW Bondi","year":"2014","unstructured":"Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, et al. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014;42(1):275\u201389. https:\/\/doi.org\/10.3233\/JAD-140276.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"811_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"811_CR23","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology. 2005;65(12):1863\u201372. https:\/\/doi.org\/10.1212\/01.wnl.0000187889.17253.b1.","journal-title":"Neurology."},{"key":"811_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.neuroimage.2016.12.077","volume":"147","author":"G Gonzalez-Escamilla","year":"2017","unstructured":"Gonzalez-Escamilla G, Lange C, Teipel S, Buchert R, Grothe MJ. Alzheimer's disease neuroimaging I. PETPVE12: an SPM toolbox for partial volume effects correction in brain PET - application to amyloid imaging with AV45-PET. Neuroimage. 2017;147:669\u201377. https:\/\/doi.org\/10.1016\/j.neuroimage.2016.12.077.","journal-title":"Neuroimage."},{"issue":"1","key":"811_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15(1):273\u201389. https:\/\/doi.org\/10.1006\/nimg.2001.0978.","journal-title":"Neuroimage."},{"issue":"1","key":"811_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-clinpsy-032816-045136","volume":"13","author":"LA Rabin","year":"2017","unstructured":"Rabin LA, Smart CM, Amariglio RE. Subjective cognitive decline in preclinical Alzheimer\u2019s disease. Annu Rev Clin Psychol. 2017;13(1):369\u201396. https:\/\/doi.org\/10.1146\/annurev-clinpsy-032816-045136.","journal-title":"Annu Rev Clin Psychol"},{"issue":"Pt 8","key":"811_CR27","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/brain\/aww108","volume":"139","author":"H Oh","year":"2016","unstructured":"Oh H, Madison C, Baker S, Rabinovici G, Jagust W. Dynamic relationships between age, amyloid-beta deposition, and glucose metabolism link to the regional vulnerability to Alzheimer\u2019s disease. Brain. 2016;139(Pt 8):2275\u201389. https:\/\/doi.org\/10.1093\/brain\/aww108.","journal-title":"Brain."},{"key":"811_CR28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3389\/fpsyt.2020.00793","volume":"11","author":"DM Hedderich","year":"2020","unstructured":"Hedderich DM, Drost R, Goldhardt O, Ortner M, Muller-Sarnowski F, Diehl-Schmid J, et al. Regional cerebral associations between psychometric tests and imaging biomarkers in Alzheimer\u2019s disease. Front Psychiatry. 2020;11:793. https:\/\/doi.org\/10.3389\/fpsyt.2020.00793.","journal-title":"Front Psychiatry"},{"key":"811_CR29","doi-asserted-by":"publisher","unstructured":"Krell-Roesch J, Syrjanen JA, Vassilaki M, Lowe VJ, Vemuri P, Mielke MM, et al. Brain regional glucose metabolism, neuropsychiatric symptoms, and the risk of incident mild cognitive impairment: the Mayo Clinic study of aging. Am J Geriatr Psychiatry. 2021;29(2):179\u201391. https:\/\/doi.org\/10.1016\/j.jagp.2020.06.006.","DOI":"10.1016\/j.jagp.2020.06.006"},{"issue":"2","key":"811_CR30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3233\/JAD-151084","volume":"52","author":"SL Gardener","year":"2016","unstructured":"Gardener SL, Sohrabi HR, Shen KK, Rainey-Smith SR, Weinborn M, Bates KA, et al. Cerebral glucose metabolism is associated with verbal but not visual memory performance in community-dwelling older adults. J Alzheimers Dis. 2016;52(2):661\u201372. https:\/\/doi.org\/10.3233\/JAD-151084.","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"811_CR31","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jalz.2015.03.003","volume":"11","author":"SL Risacher","year":"2015","unstructured":"Risacher SL, Kim S, Nho K, Foroud T, Shen L, Petersen RC, et al. APOE effect on Alzheimer\u2019s disease biomarkers in older adults with significant memory concern. Alzheimers Dement. 2015;11(12):1417\u201329. https:\/\/doi.org\/10.1016\/j.jalz.2015.03.003.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"811_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1474-4422(18)30029-2","volume":"17","author":"B Dubois","year":"2018","unstructured":"Dubois B, Epelbaum S, Nyasse F, Bakardjian H, Gagliardi G, Uspenskaya O, et al. Cognitive and neuroimaging features and brain beta-amyloidosis in individuals at risk of Alzheimer\u2019s disease (INSIGHT-preAD): a longitudinal observational study. Lancet Neurol. 2018;17(4):335\u201346. https:\/\/doi.org\/10.1016\/S1474-4422(18)30029-2.","journal-title":"Lancet Neurol"},{"issue":"1","key":"811_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/0284185114566088","volume":"57","author":"IU Song","year":"2016","unstructured":"Song IU, Choi EK, Oh JK, Chung YA, Chung SW. Alteration patterns of brain glucose metabolism: comparisons of healthy controls, subjective memory impairment and mild cognitive impairment. Acta Radiol. 2016;57(1):90\u20137. https:\/\/doi.org\/10.1177\/0284185114566088.","journal-title":"Acta Radiol"},{"issue":"1","key":"811_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/JAD-121684","volume":"39","author":"A Brugnolo","year":"2014","unstructured":"Brugnolo A, Morbelli S, Arnaldi D, De Carli F, Accardo J, Bossert I, et al. Metabolic correlates of Rey auditory verbal learning test in elderly subjects with memory complaints. J Alzheimers Dis. 2014;39(1):103\u201313. https:\/\/doi.org\/10.3233\/JAD-121684.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"811_CR35","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jagp.2017.02.002","volume":"25","author":"JA Matias-Guiu","year":"2017","unstructured":"Matias-Guiu JA, Cabrera-Martin MN, Valles-Salgado M, Perez-Perez A, Rognoni T, Moreno-Ramos T, et al. Neural basis of cognitive assessment in Alzheimer disease, amnestic mild cognitive impairment, and subjective memory complaints. Am J Geriatr Psychiatry. 2017;25(7):730\u201340. https:\/\/doi.org\/10.1016\/j.jagp.2017.02.002.","journal-title":"Am J Geriatr Psychiatry"},{"key":"811_CR36","doi-asserted-by":"publisher","unstructured":"Beason-Held LL, Shafer AT, Goh JO, Landman BA, Davatzikos C, Viscomi B, et al. Hippocampal activation and connectivity in the aging brain. Brain Imaging Behav. 2020. https:\/\/doi.org\/10.1007\/s11682-020-00279-6.","DOI":"10.1007\/s11682-020-00279-6"},{"issue":"6597","key":"811_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/383254a0","volume":"383","author":"R Vandenberghe","year":"1996","unstructured":"Vandenberghe R, Price C, Wise R, Josephs O, Frackowiak RS. Functional anatomy of a common semantic system for words and pictures. Nature. 1996;383(6597):254\u20136. https:\/\/doi.org\/10.1038\/383254a0.","journal-title":"Nature."},{"issue":"11","key":"811_CR38","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s12149-020-01506-2","volume":"34","author":"G Xu","year":"2020","unstructured":"Xu G, Zheng S, Zhu Z, Yu X, Jiang J, Jiang J, et al. Association of tau accumulation and atrophy in mild cognitive impairment: a longitudinal study. Ann Nucl Med. 2020;34(11):815\u201323. https:\/\/doi.org\/10.1007\/s12149-020-01506-2.","journal-title":"Ann Nucl Med"},{"issue":"Pt 12","key":"811_CR39","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1093\/brain\/awv283","volume":"138","author":"CR Jack Jr","year":"2015","unstructured":"Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Mielke MM, Vemuri P, et al. Different definitions of neurodegeneration produce similar amyloid\/neurodegeneration biomarker group findings. Brain. 2015;138(Pt 12):3747\u201359. https:\/\/doi.org\/10.1093\/brain\/awv283.","journal-title":"Brain."},{"issue":"10","key":"811_CR40","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00234-010-0795-1","volume":"53","author":"X Li","year":"2011","unstructured":"Li X, Coyle D, Maguire L, Watson DR, McGinnity TM. Gray matter concentration and effective connectivity changes in Alzheimer's disease: a longitudinal structural MRI study. Neuroradiology. 2011;53(10):733\u201348. https:\/\/doi.org\/10.1007\/s00234-010-0795-1.","journal-title":"Neuroradiology."},{"key":"811_CR41","first-page":"920902","volume":"2014","author":"Z Zhao","year":"2014","unstructured":"Zhao Z, Lu J, Jia X, Chao W, Han Y, Jia J, et al. Selective changes of resting-state brain oscillations in aMCI: an fMRI study using ALFF. Biomed Res Int. 2014;2014:920902.","journal-title":"Biomed Res Int"},{"issue":"1","key":"811_CR42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.neuroimage.2012.04.051","volume":"62","author":"Z Wang","year":"2012","unstructured":"Wang Z, Liu J, Zhong N, Qin Y, Zhou H, Li K. Changes in the brain intrinsic organization in both on-task state and post-task resting state. Neuroimage. 2012;62(1):394\u2013407. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.04.051.","journal-title":"Neuroimage."},{"issue":"4","key":"811_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.12779\/dnd.2019.18.4.113","volume":"18","author":"EY Lim","year":"2019","unstructured":"Lim EY, Shim YS, Hong YJ, Ryu SY, Cho AH, Yang DW. Different cortical thinning patterns depending on their prognosis in individuals with subjective cognitive decline. Dement Neurocogn Disord. 2019;18(4):113\u201321. https:\/\/doi.org\/10.12779\/dnd.2019.18.4.113.","journal-title":"Dement Neurocogn Disord"},{"issue":"3","key":"811_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.neuropsychologia.2005.06.012","volume":"44","author":"HJ Rosen","year":"2006","unstructured":"Rosen HJ, Wilson MR, Schauer GF, Allison S, Gorno-Tempini ML, Pace-Savitsky C, et al. Neuroanatomical correlates of impaired recognition of emotion in dementia. Neuropsychologia. 2006;44(3):365\u201373. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2005.06.012.","journal-title":"Neuropsychologia."},{"issue":"2","key":"811_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0197-4580(02)00084-2","volume":"24","author":"GF Busatto","year":"2003","unstructured":"Busatto GF, Garrido GE, Almeida OP, Castro CC, Camargo CH, Cid CG, et al. A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer's disease. Neurobiol Aging. 2003;24(2):221\u201331. https:\/\/doi.org\/10.1016\/S0197-4580(02)00084-2.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"811_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1053-8119(03)00273-8","volume":"20","author":"NS White","year":"2003","unstructured":"White NS, Alkire MT, Haier RJ. A voxel-based morphometric study of nondemented adults with Down syndrome. Neuroimage. 2003;20(1):393\u2013403. https:\/\/doi.org\/10.1016\/S1053-8119(03)00273-8.","journal-title":"Neuroimage."},{"issue":"4","key":"811_CR47","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ana.92","volume":"49","author":"D Chan","year":"2001","unstructured":"Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, Leschziner G, et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol. 2001;49(4):433\u201342. https:\/\/doi.org\/10.1002\/ana.92.","journal-title":"Ann Neurol"},{"issue":"11","key":"811_CR48","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1093\/brain\/awq272","volume":"133","author":"M Mion","year":"2010","unstructured":"Mion M, Patterson K, Acosta-Cabronero J, Pengas G, Izquierdo-Garcia D, Hong YT, et al. What the left and right anterior fusiform gyri tell us about semantic memory. Brain. 2010;133(11):3256\u201368. https:\/\/doi.org\/10.1093\/brain\/awq272.","journal-title":"Brain."},{"issue":"1","key":"811_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0925-4927(01)00126-3","volume":"114","author":"MW Willis","year":"2002","unstructured":"Willis MW, Ketter TA, Kimbrell TA, George MS, Herscovitch P, Danielson AL, et al. Age, sex and laterality effects on cerebral glucose metabolism in healthy adults. Psychiatry Res. 2002;114(1):23\u201337. https:\/\/doi.org\/10.1016\/S0925-4927(01)00126-3.","journal-title":"Psychiatry Res"},{"issue":"1","key":"811_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1479-8301.2010.00350.x","volume":"11","author":"T Yoshida","year":"2011","unstructured":"Yoshida T, Kazui H, Tokunaga H, Kito Y, Kubo Y, Kimura N, et al. Protein synthesis in the posterior cingulate cortex in Alzheimer\u2019s disease. Psychogeriatrics. 2011;11(1):40\u20135. https:\/\/doi.org\/10.1111\/j.1479-8301.2010.00350.x.","journal-title":"Psychogeriatrics."},{"key":"811_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.arr.2016.02.003","volume":"30","author":"T Kato","year":"2016","unstructured":"Kato T, Inui Y, Nakamura A, Ito K. Brain fluorodeoxyglucose (FDG) PET in dementia. Ageing Res Rev. 2016;30:73\u201384. https:\/\/doi.org\/10.1016\/j.arr.2016.02.003.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"811_CR52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jalz.2013.05.1764","volume":"10","author":"J Peter","year":"2014","unstructured":"Peter J, Scheef L, Abdulkadir A, Boecker H, Heneka M, Wagner M, et al. Gray matter atrophy pattern in elderly with subjective memory impairment. Alzheimers Dement. 2014;10(1):99\u2013108. https:\/\/doi.org\/10.1016\/j.jalz.2013.05.1764.","journal-title":"Alzheimers Dement"},{"key":"811_CR53","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3389\/fnins.2018.00975","volume":"12","author":"L Yang","year":"2018","unstructured":"Yang L, Yan Y, Wang Y, Hu X, Lu J, Chan P, et al. Gradual disturbances of the amplitude of low-frequency fluctuations (ALFF) and fractional ALFF in Alzheimer spectrum. Front Neurosci. 2018;12:975. https:\/\/doi.org\/10.3389\/fnins.2018.00975.","journal-title":"Front Neurosci"},{"issue":"3","key":"811_CR54","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3233\/JAD-181049","volume":"68","author":"T Yan","year":"2019","unstructured":"Yan T, Wang Y, Weng Z, Du W, Liu T, Chen D, et al. Early-stage identification and pathological development of Alzheimer\u2019s disease using multimodal MRI. J Alzheimers Dis. 2019;68(3):1013\u201327. https:\/\/doi.org\/10.3233\/JAD-181049.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"811_CR55","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jpsychires.2009.09.012","volume":"44","author":"S Forster","year":"2010","unstructured":"Forster S, Teipel S, Zach C, Rominger A, Cumming P, Fougere C, et al. FDG-PET mapping the brain substrates of visuo-constructive processing in Alzheimer\u2019s disease. J Psychiatr Res. 2010;44(7):462\u20139. https:\/\/doi.org\/10.1016\/j.jpsychires.2009.09.012.","journal-title":"J Psychiatr Res"},{"issue":"7","key":"811_CR56","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1080\/13803395.2016.1255312","volume":"39","author":"AM Staffaroni","year":"2017","unstructured":"Staffaroni AM, Melrose RJ, Leskin LP, Riskin-Jones H, Harwood D, Mandelkern M, et al. The functional neuroanatomy of verbal memory in Alzheimer\u2019s disease: [(18) F]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) correlates of recency and recognition memory. J Clin Exp Neuropsychol. 2017;39(7):682\u201393. https:\/\/doi.org\/10.1080\/13803395.2016.1255312.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"7","key":"811_CR57","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.clinph.2017.05.003","volume":"128","author":"Z Guo","year":"2017","unstructured":"Guo Z, Liu X, Li J, Wei F, Hou H, Chen X, et al. Fractional amplitude of low-frequency fluctuations is disrupted in Alzheimer\u2019s disease with depression. Clin Neurophysiol. 2017;128(7):1344\u20139. https:\/\/doi.org\/10.1016\/j.clinph.2017.05.003.","journal-title":"Clin Neurophysiol"},{"key":"811_CR58","doi-asserted-by":"publisher","unstructured":"Ward MA, Bendlin BB, McLaren DG, Hess TM, Gallagher CL, Kastman EK, et al. Low HDL cholesterol is associated with lower gray matter volume in cognitively healthy adults. Front Aging Neurosci. 2010;2(29):1\u20138. https:\/\/doi.org\/10.3389\/fnagi.2010.00029.","DOI":"10.3389\/fnagi.2010.00029"},{"issue":"1","key":"811_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13195-019-0514-z","volume":"11","author":"E Kuhn","year":"2019","unstructured":"Kuhn E, Moulinet I, Perrotin A, La Joie R, Landeau B, Tomadesso C, et al. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time. Alzheimers Res Ther. 2019;11(1):61. https:\/\/doi.org\/10.1186\/s13195-019-0514-z.","journal-title":"Alzheimers Res Ther"},{"issue":"29","key":"811_CR60","doi-asserted-by":"publisher","first-page":"10402","DOI":"10.1523\/JNEUROSCI.0150-15.2015","volume":"35","author":"FL Besson","year":"2015","unstructured":"Besson FL, La Joie R, Doeuvre L, Gaubert M, Mezenge F, Egret S, et al. Cognitive and brain profiles associated with current neuroimaging biomarkers of preclinical Alzheimer\u2019s disease. J Neurosci. 2015;35(29):10402\u201311. https:\/\/doi.org\/10.1523\/JNEUROSCI.0150-15.2015.","journal-title":"J Neurosci"},{"issue":"50","key":"811_CR61","doi-asserted-by":"publisher","first-page":"18227","DOI":"10.1523\/JNEUROSCI.3266-12.2012","volume":"32","author":"WJ Jagust","year":"2012","unstructured":"Jagust WJ, Landau SM. Alzheimer\u2019s disease neuroimaging I. Apolipoprotein E, not fibrillar beta-amyloid, reduces cerebral glucose metabolism in normal aging. J Neurosci. 2012;32(50):18227\u201333. https:\/\/doi.org\/10.1523\/JNEUROSCI.3266-12.2012.","journal-title":"J Neurosci"},{"issue":"9","key":"811_CR62","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","volume":"91","author":"AJ Aschenbrenner","year":"2018","unstructured":"Aschenbrenner AJ, Gordon BA, Benzinger TLS, Morris JC, Hassenstab JJ. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. 2018;91(9):e859\u2013e66. https:\/\/doi.org\/10.1212\/WNL.0000000000006075.","journal-title":"Neurology."},{"issue":"8","key":"811_CR63","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, et al. Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol. 2019;76(8):915. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1424.","journal-title":"JAMA Neurol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00811-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00811-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00811-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T08:42:38Z","timestamp":1632472958000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00811-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00811-w","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"15 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Medical Ethics Committee of Xuanwu Hospital of Capital Medical University and was carried out in accordance with the Declaration of Helsinki. The Journal\u2019s position on issues involved in ethical publication were read and affirm that this report is consistent with those guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"On behalf of all authors, the corresponding author confirms no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}